11 net new LifeSphere customers, 57 customer go-lives, and expanded adoption of NavaX BOSTON, Jan. 29, 2025 /PRNewswire/ -- ArisGlobal, an…
SAN FRANCISCO, Jan. 29, 2025 /PRNewswire/ -- Medrio, a global leader in clinical trial technology, today announced the release of AI-enabled…
NEW YORK, Jan. 29, 2025 /PRNewswire/ -- Princeton Biopartners, a best-in-class provider of integrated consulting solutions to the life sciences sector,…
The latest addition to the Navigator365™ Omnichannel product family transforms how life sciences companies engage with digital influencers through actionable insights…
Biopharmas use leading CTMS for improved trial efficiency and collaboration PLEASANTON, Calif., Jan. 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE:…
Completion enables the End-of-Phase 2 (EOP2) interaction with the FDA on the design of the Phase 3 program and is…
Carlsbad, CA, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical…
VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company advancing innovative cancer…
VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”)…
FLORHAM PARK, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing…